LEROCHOL 300 mg/1.2mL
lerodalcibep-liga · INJECTION, SOLUTION · LIB Therapeutics, Inc.
LEROCHOL is a injection, solution containing lerodalcibep-liga at 300 mg/1.2mL, taken subcutaneous. Manufactured by LIB Therapeutics, Inc..
Key Facts
- Brand Name
- LEROCHOL
- Generic Name
- lerodalcibep-liga
- NDC Code (Product)
84685-300- Manufacturer
- LIB Therapeutics, Inc.
- Strength
- 300 mg/1.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761427
- Marketing Start
- 12/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is LEROCHOL used for?
LEROCHOL contains lerodalcibep-liga. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is LEROCHOL a controlled substance?
LEROCHOL is not classified as a controlled substance by the DEA.
What is the generic name for LEROCHOL?
The generic name for LEROCHOL is lerodalcibep-liga. There are no other listed brand versions of lerodalcibep-liga.
What is the NDC code for LEROCHOL 300 mg/1.2mL?
The NDC (National Drug Code) for LEROCHOL 300 mg/1.2mL is 84685-300, listed by LIB Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)